Loading...
XJPX
3937
Market cap85mUSD
Oct 09, Last price  
1,146.00JPY
1D
2.78%
1Q
14.60%
Jan 2017
56.24%
IPO
20.63%
Name

Ubicom Holdings Inc

Chart & performance

D1W1MN
XJPX:3937 chart
P/E
15.58
P/S
2.32
EPS
73.56
Div yield, %
3.59%
Shrs. gr., 5y
0.12%
Rev. gr., 5y
7.38%
Revenues
5.99b
-5.49%
2,396,000,0002,589,857,0002,926,896,0002,992,365,0003,208,342,0003,555,013,0004,038,254,0004,198,116,0004,726,359,0005,246,671,0005,942,642,0006,340,989,0005,992,564,000
Net income
892m
+3.89%
-160,000,00032,032,000-4,747,000112,464,000212,775,000368,566,000533,345,000623,767,000832,144,000573,793,000526,143,000858,398,000891,779,000
CFO
984m
+5.72%
094,030,000114,352,000149,210,000294,891,000567,998,000498,598,000921,738,000874,138,000820,657,000726,899,000930,831,000984,068,000
Dividend
Mar 30, 202640 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ubicom Holdings, Inc., established in Tokyo, Japan in 2005, delivers comprehensive information technology (IT) solutions primarily within Japan and across Asia. The company's diverse offerings encompass application development and testing, embedded software, and quality assurance, alongside advanced services in artificial intelligence, data analytics, and various automation technologies, including Robotic Process Automation (RPA). Beyond general IT, Ubicom specializes in medical IT solutions for hospitals and clinics. These include support for receipt processing, medical safety, data analysis, cloud services, development assistance, and consulting, all designed to navigate shifts in medical systems and mitigate labor shortages. The corporation adopted its current name, Ubicom Holdings, Inc., in July 2017, having previously been known as AWS Holdings, Inc.

Key people

Katsumi Murayama
Senior Executive Officer · since 2024
Naoki Takahashi
Senior Executive Officer, Director of R&D Transformation Strategy in Main Technology Consulting Business Unit · since 2024
Naoko Noguchi
Executive Officer, Chief Financial Officer, Senior Director of Finance and Accounting, Senior Director of General Affairs and Human Resources · since 2025
Shingo Chiba
Executive Officer · since 2024
Yasutaka Kawakita
Executive Officer · since 2024
Kazuhide Miyoshi
Executive Officer · since 2025
Vincent Remo
Executive Officer, Director of Overseas Operations Strategy in Main Technology Consulting Business Unit · since 2024
Peter Tan
Executive Officer, Director of AI Strategy Business in Main Technology Consulting Business Unit · since 2024
Nanju Zen
Executive Officer, Director of Transformation Strategy Business in Main Technology Consulting Business Unit · since 2025
Masayuki Aoki
President, Chief Executive Officer, Chairman and President of Subsidiary, Representative Director · since 2023
Akisato Kitaoka
Senior Executive Officer, Chief Director of Medical Business, Chief Director of Corporate Strategy, Manager of Business Planning Office, Director · since 2024
Yoshinori Hashitani
Independent Director · since 2019
Natsumi Horikawa
Independent Director · since 2025
Toshiyuki Ito
Independent Director · since 2019
Independent Director · since 2023
Taisuke Tsuyuguchi
Independent Director · since 2025
IPO date
Jun 21, 2016
Employees
1,065
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT